Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Mendus

4.06 SEK

-5.58 %

Less than 1K followers

IMMU

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Mendus

EV/S

Median 2019-2022

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)193.79136.3278.9444.4010.467.805.60
Shares5.09.010.810.843.250.462.6
Market cap970.51,229.6854.4480.6451.4392.9350.5
Enterprise value673.71,063.2699.4464.8354.3312.8-
EV/S754.5-22,562.2137.5---
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B3.561.861.300.930.640.610.60
P/S1,086.8-27,562.4142.2---
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio89.8 %90.7 %91.1 %82.9 %93.2 %92.6 %93.1 %
Gearing ratio-0.2 %0.0 %5.1 %3.4 %3.4 %3.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.